Annual Working Capital
$786.60 M
-$451.12 M-36.45%
December 31, 2023
Summary
- As of February 7, 2025, SAGE annual working capital is $786.60 million, with the most recent change of -$451.12 million (-36.45%) on December 31, 2023.
- During the last 3 years, SAGE annual working capital has fallen by -$1.27 billion (-61.73%).
- SAGE annual working capital is now -61.73% below its all-time high of $2.06 billion, reached on December 31, 2020.
Performance
SAGE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$544.58 M
-$73.19 M-11.85%
September 30, 2024
Summary
- As of February 7, 2025, SAGE quarterly working capital is $544.58 million, with the most recent change of -$73.19 million (-11.85%) on September 30, 2024.
- Over the past year, SAGE quarterly working capital has dropped by -$73.19 million (-11.85%).
- SAGE quarterly working capital is now -73.50% below its all-time high of $2.06 billion, reached on December 31, 2020.
Performance
SAGE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SAGE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.5% | -11.8% |
| 3 y3 years | -61.7% | -70.1% |
| 5 y5 years | -8.4% | -48.7% |
SAGE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.1% | at low | -68.3% | at low |
| 5 y | 5-year | -61.7% | at low | -73.5% | at low |
| alltime | all time | -61.7% | >+9999.0% | -73.5% | +8839.3% |
Sage Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $544.58 M(-11.8%) |
| Jun 2024 | - | $617.77 M(-10.9%) |
| Mar 2024 | - | $693.64 M(-11.8%) |
| Dec 2023 | $786.60 M(-36.4%) | $786.60 M(-1.7%) |
| Sep 2023 | - | $800.27 M(-17.3%) |
| Jun 2023 | - | $967.22 M(-13.5%) |
| Mar 2023 | - | $1.12 B(-9.6%) |
| Dec 2022 | $1.24 B(-27.8%) | $1.24 B(-9.4%) |
| Sep 2022 | - | $1.37 B(-8.3%) |
| Jun 2022 | - | $1.49 B(-7.2%) |
| Mar 2022 | - | $1.60 B(-6.5%) |
| Dec 2021 | $1.72 B(-16.5%) | $1.72 B(-5.9%) |
| Sep 2021 | - | $1.82 B(-4.9%) |
| Jun 2021 | - | $1.92 B(-3.7%) |
| Mar 2021 | - | $1.99 B(-3.2%) |
| Dec 2020 | $2.06 B(+122.7%) | $2.06 B(+221.5%) |
| Sep 2020 | - | $639.22 M(-11.4%) |
| Jun 2020 | - | $721.09 M(-12.9%) |
| Mar 2020 | - | $827.88 M(-10.3%) |
| Dec 2019 | $922.97 M | $922.97 M(-13.1%) |
| Sep 2019 | - | $1.06 B(-10.4%) |
| Jun 2019 | - | $1.18 B(-9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $1.30 B(+51.8%) |
| Dec 2018 | $858.66 M(+81.5%) | $858.66 M(-12.9%) |
| Sep 2018 | - | $985.39 M(-8.4%) |
| Jun 2018 | - | $1.08 B(+1.8%) |
| Mar 2018 | - | $1.06 B(+123.5%) |
| Dec 2017 | $473.12 M(+28.8%) | $473.12 M(+138.3%) |
| Sep 2017 | - | $198.51 M(-23.3%) |
| Jun 2017 | - | $258.84 M(-18.4%) |
| Mar 2017 | - | $317.16 M(-13.7%) |
| Dec 2016 | $367.41 M(+112.2%) | $367.41 M(-10.9%) |
| Sep 2016 | - | $412.36 M(+61.2%) |
| Jun 2016 | - | $255.77 M(-10.8%) |
| Mar 2016 | - | $286.64 M(+65.5%) |
| Dec 2015 | $173.18 M(+43.1%) | $173.18 M(-12.2%) |
| Sep 2015 | - | $197.19 M(-8.9%) |
| Jun 2015 | - | $216.51 M(+105.1%) |
| Mar 2015 | - | $105.58 M(-12.8%) |
| Dec 2014 | $121.06 M(+1887.3%) | $121.06 M(-8.8%) |
| Sep 2014 | - | $132.78 M(+178.9%) |
| Jun 2014 | - | $47.61 M(-11.1%) |
| Mar 2014 | - | $53.57 M(+779.4%) |
| Dec 2013 | $6.09 M(+333.0%) | $6.09 M |
| Dec 2012 | $1.41 M | - |
FAQ
- What is Sage Therapeutics annual working capital?
- What is the all time high annual working capital for Sage Therapeutics?
- What is Sage Therapeutics annual working capital year-on-year change?
- What is Sage Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Sage Therapeutics?
- What is Sage Therapeutics quarterly working capital year-on-year change?
What is Sage Therapeutics annual working capital?
The current annual working capital of SAGE is $786.60 M
What is the all time high annual working capital for Sage Therapeutics?
Sage Therapeutics all-time high annual working capital is $2.06 B
What is Sage Therapeutics annual working capital year-on-year change?
Over the past year, SAGE annual working capital has changed by -$451.12 M (-36.45%)
What is Sage Therapeutics quarterly working capital?
The current quarterly working capital of SAGE is $544.58 M
What is the all time high quarterly working capital for Sage Therapeutics?
Sage Therapeutics all-time high quarterly working capital is $2.06 B
What is Sage Therapeutics quarterly working capital year-on-year change?
Over the past year, SAGE quarterly working capital has changed by -$73.19 M (-11.85%)